Medical Health & Life Science Research News

Global radiopharmaceuticals market with high CAGR of 8.7% till 2024 insights shared in detailed report

Data Bridge Market Research added new industry report "Global Radiopharmaceuticals Market" is expected to reach USD 9.49 billion by 2024 from USD 4.87 billion in 2016, at a CAGR of 8.7% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Definition of Global Radiopharmaceuticals Market

Radiopharmaceuticals Make an Inquiry about this news are a group of pharmaceuticals drug which have radioactivity. It can be used as diagnostic and therapeutic agent.

Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical area for diagnosis or therapy. The procedures and facilities for the production, use, and storage of radiopharmaceuticals are subject to licensing by national or regional authorities.

This licensing includes compliance both with governing radioactive materials and with those regulations governing pharmaceutical preparations. Additional regulations may apply for issues such as transportation or dispensing of radiopharmaceuticals.

Ask for Sample Report Visit @…aceuticals-market Make an Inquiry about this news

Global Radiopharmaceuticals Market are included brief analysis of following points:

  • Macro Indicator Analysis
  • Market Overview
  • Market Dynamics
  • Drivers, Restraints, Opportunities and Challenges
  • Market sizing and growth analysis
  • Market forecasting to 2024
  • Market Competitive Landscape
  • Product Launches and Pipeline Analysis
  • Value Chain Analysis
  • Market Mergers, Acquisitions and Agreements
  • Company Profiles

Market Segmentation:

The global market is segmented based on type, procedural volumes, application, sources, end-user, and geography.

On the basis of type, the global radiopharmaceuticals market Make an Inquiry about this news is sub-segmented into

  • Diagnostic
  • Therapeutic radiopharmaceuticals.

In 2017, diagnostic radiopharmaceuticals segment dominate the market and is expected to grow at the highest in the forecast period. This is due to the production of MO-99 in the U.S., FDA approvals of radiopharmaceuticals, initiatives of International Atomic Energy Agency (IAEA), new irradiation facility in Germany, installation of PET scanners in India, andgovernment investments in Rest of Asia-Pacific.

On the basis of procedural volumes, the global radiopharmaceuticals market is sub-segmented into

  1. Diagnostic procedure
  • single-photon emission computed tomography (SPECT) radiopharmaceuticals
  • positron emission tomography (PET) radiopharmaceuticals
  1. Therapeutic procedures
  • beta emitters
  • alpha emitters
  • brachy therapy

On the basis of application, the global radiopharmaceuticals market is sub-segmented into

  1. diagnostic application
  • single-photon emission computed tomography (SPECT) -
  • positron emission tomography (PET)- oncology, cardiology, neurology and others
  1. therapeutic application
  • thyroid,
  • bone metastasis,
  • lymphoma,
  • endocrine tumours
  • others

On the basis of sources, the global radiopharmaceuticals market is sub-segmented into

  • nuclear reactors
  • cyclotrons

On the basis of end user, the global radiopharmaceuticals market is sub-segmented into

  • hospitals,
  • ambulatory surgical centers,
  • diagnostic centers,
  • cancer research institutes and
  • others

 In 2017, hospital segment dominate the market with the highest market share due to accessibility of highly skilled medical practitioners in the radiology departments of hospitals.

Request for Table of Content of Full Report @…aceuticals-market Make an Inquiry about this news

Top Competitors:

  • Cardinal Health Inc.
  • MallinckrodtPlc.
  • GE Healthcare
  • Lantheus Medical Imaging Inc.
  • Bayer AG
  • Bracco Imaging SpA
  • Eczacibasi-Monrol Nuclear Products
  • Nordion Inc.
  • Advanced Accelerator Applications S.A.
  • IBA Molecular Imaging
  • CovidienPlc
  • Positron Corporation
  • NTP Radioisotopes Pty. Ltd.
  • Advanced Medical Isotope Corporation
  • Avid Radiopharmaceuticals
  • Jubilant Pharma
  • Actinium Pharmaceuticals Inc.,
  • Among others.

Read more about Report Visit @…ceuticals-market/ Make an Inquiry about this news

News From

Data Bridge Market ResearchData Bridge Market Research
Category: Market Research Publishers and RetailersCompany about: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
This email address is being protected from spambots. You need JavaScript enabled to view it.

For more information:

Make an Inquiry about this report HERE!